Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells
Tiancheng Liu1, Desiree E Mendes1, Clifford E Berkman1
1Department of Chemistry, Washington State University, Pullman, WA 99164, USA.
International Journal of Oncology
|January 16, 2014
Summary
Prostate-specific membrane antigen (PSMA) is found in exosomes secreted by prostate cancer cells. Exosomal PSMA retains enzymatic activity, offering potential for non-invasive prostate cancer diagnosis and prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate cancer diagnosis and prognosis require effective tumor marker detection.
- Prostate-specific membrane antigen (PSMA) is a key marker for prostate cancer progression, including angiogenesis and metastasis.
- PSMA, a type II membrane protein, is internalized into endosomes and can be secreted via exosomes.
Purpose of the Study:
- To investigate whether endosomal PSMA is transferred to exosomes.
- To explore the potential of exosomal PSMA as an extracellular resource for prostate cancer detection.
Main Methods:
- PSMA-positive LNCaP cells were cultured to collect and isolate secreted exosomes.
- Exosome characterization involved electron microscopy and western blot analysis for exosomal markers (CD9, TSG101).
- Exosomal PSMA was analyzed for glycosylation, proteolysis, and enzymatic activity via in vitro assays.
Main Results:
- PSMA was found to be enriched in secreted exosomes compared to cellular PSMA.
- Exosomal PSMA exhibited higher glycosylation and partial proteolysis.
- In vitro enzyme assays confirmed that exosomal PSMA retains functional enzymatic activity.
Conclusions:
- PSMA is present and functional in exosomes derived from prostate cancer cells.
- Exosomal PSMA may play a role in prostate cancer progression.
- These findings suggest novel non-invasive approaches for prostate cancer diagnosis and prognosis.
